For example, TGF-β1 can stimulate tumor cells to express laminin γ2 via the JNK/AP1 signaling pathway, affecting T-cell receptor gene transcription and chemotaxis, contributing to ineffective anti-PD-1 therapy. The gene discussed is JUN; the disease is neoplasm.